Melola Discovery

← Melola Discovery

Jurnal

In Silico Study of Secondary Metabolite Compounds in Parsley (Petroselinum crispum) as a Drug Therapy for Blood Cancer (Myeloproliferative Neoplasm (MPN)) targeting JAK-2

Indonesian Journal of Chemical Science · Vol. 12 No. 2 (2023) · hlm. 212–224

DOI
10.15294/ijcs.v12i2.69942
ISSN
2502-6844, 2252-6951
Terbit
2023-08-27
Penerbit
Universitas Negeri Semarang
Bahasa
eng

Abstrak

Myeloproliferative neoplasm (MPN) is a clonal hematopoietic stem cell disorder. A commonly found related gene mutation is a mutation of the JAK2 kinase, thus making it a potential MPN pharmacotherapeutic target. One such pharmacotherapeutic agent with this mechanism is Ruxolitinib, which has anemia and thrombocytopenia as side effects. Based on literature, the parsley herb has a potential as an anticancer. The activity of the secondary metabolites of parsley herb were tested on JAK2 in-silico, with the goal being to develop a potential MPN pharmacotherapeutic agent candidate with minimized side effects. This was done by redocking a native ligand (5-amino-3-[(4-cyanophenyl)amino]-N-phenyl-1H-1,2,4-triazole-1-carboxamide) and docking 15 test ligands which are secondary metabolites of parsley herb to JAK2. The Gridbox that was used is situated on x center: 10.06, y center -7.342, z center -20.32 with 0.375 Å units. The test ligand with the best binding potential to JAK2 is luteolin, with a binding energy of -8.13, inhibition constant of 1.1, hydrogen bonds on GLN A: 553, SER A: 698, LYS A: 581, GLN A: 626 VAL A: 629, and other bond types on ILE A: 559, LEU A: 579, LEU A: 680.

Jaringan kolaborasi para penulis

22 penulis · 75 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Padjadjaran University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Martina AnjelinaAfiliasi tidak diketahui2
Fahri RenaldiAfiliasi tidak diketahui2
Kalya Kama ShabiraAfiliasi tidak diketahui2
Selly Trianingrum FebriyantiAfiliasi tidak diketahui2
Rina Fajri NuwardaAfiliasi tidak diketahui2
Nafisa Nurfatia HidayatAfiliasi tidak diketahui1
Fitri Azlia KhaeraniAfiliasi tidak diketahui1
Prodio Efa GaharaniAfiliasi tidak diketahui1
Nataszna Ribielle MeiruPadjadjaran University1
Muhammad Fikri AlvaroPadjadjaran University1
Meika Fatia KayraniPadjadjaran University1
Rania SalsabilaPadjadjaran University1
Adeline MargaretPadjadjaran University1
Risna Maulida SetiawanPadjadjaran University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://journal.unnes.ac.id/sju/index.php/ijcs/oai, pertama di-harvest 5 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">In Silico Study of Secondary Metabolite Compounds in Parsley (Petroselinum crispum) as a Drug Therapy for Blood Cancer (Myeloproliferative Neoplasm (MPN)) targeting JAK-2</dc:title>
	<dc:creator>Wulandari, Rizky Prasiska</dc:creator>
	<dc:creator>Gabriel, Kevin</dc:creator>
	<dc:creator>Nurdin, Halwa Aulia</dc:creator>
	<dc:creator>F. Pakhrul, Diffa Hauna</dc:creator>
	<dc:creator>Harits, Sabiq Salmandhiya</dc:creator>
	<dc:creator>Prameswari, Natasya</dc:creator>
	<dc:creator>Agustina Pribadi, Alya Puteri</dc:creator>
	<dc:creator>Aulifa, Diah Lia</dc:creator>
	<dc:description xml:lang="en-US">Myeloproliferative neoplasm (MPN) is a clonal hematopoietic stem cell disorder. A commonly found related gene mutation is a mutation of the JAK2 kinase, thus making it a potential MPN pharmacotherapeutic target. One such pharmacotherapeutic agent with this mechanism is Ruxolitinib, which has anemia and thrombocytopenia as side effects. Based on literature, the parsley herb has a potential as an anticancer. The activity of the secondary metabolites of parsley herb were tested on JAK2 in-silico, with the goal being to develop a potential MPN pharmacotherapeutic agent candidate with minimized side effects. This was done by redocking a native ligand (5-amino-3-[(4-cyanophenyl)amino]-N-phenyl-1H-1,2,4-triazole-1-carboxamide) and docking 15 test ligands which are secondary metabolites of parsley herb to JAK2. The Gridbox that was used is situated on x center : 10.06, y center -7.342, z center -20.32 with 0.375 Å units. The test ligand with the best binding potential to JAK2 is luteolin, with a binding energy of -8.13, inhibition constant of 1.1, hydrogen bonds on GLN A: 553, SER A: 698, LYS A: 581, GLN A: 626 VAL A: 629, and other bond types on ILE A: 559, LEU A: 579, LEU A: 680.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Negeri Semarang</dc:publisher>
	<dc:date>2023-08-27</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.unnes.ac.id/sju/ijcs/article/view/69942</dc:identifier>
	<dc:identifier>10.15294/ijcs.v12i2.69942</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Chemical Science; Vol 12 No 2 (2023); 212-224</dc:source>
	<dc:source>2502-6844</dc:source>
	<dc:source>2252-6951</dc:source>
	<dc:source>10.15294/ijcs.v12i2</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.unnes.ac.id/sju/ijcs/article/view/69942/25069</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Indonesian Journal of Chemical Science</dc:rights>
</oai_dc:dc>